SELLAS Life Sciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLS and other ETFs, options, and stocks.About SLS
SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S.
CEOAngelos M. Stergiou
CEOAngelos M. Stergiou
Employees15
Employees15
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2006
Founded2006
Employees15
Employees15
SLS Key Statistics
Market cap642.41M
Market cap642.41M
Price-Earnings ratio-15.72
Price-Earnings ratio-15.72
Dividend yield—
Dividend yield—
Average volume10.30M
Average volume10.30M
High today$4.92
High today$4.92
Low today$4.45
Low today$4.45
Open price$4.60
Open price$4.60
Volume5.65M
Volume5.65M
52 Week high$5.18
52 Week high$5.18
52 Week low$0.8505
52 Week low$0.8505
Stock Snapshot
The current SELLAS Life Sciences(SLS) stock price is $4.53, with a market capitalization of 642.41M. The stock trades at a price-to-earnings (P/E) ratio of -15.72.
On 2026-01-23, SELLAS Life Sciences(SLS) stock moved within a range of $4.45 to $4.92. With shares now at $4.53, the stock is trading +1.9% above its intraday low and -7.9% below the session's peak.
Trading volume for SELLAS Life Sciences(SLS) stock has reached 5.65M, versus its average volume of 10.3M.
The stock's 52-week range extends from a low of $0.85 to a high of $5.18.
The stock's 52-week range extends from a low of $0.85 to a high of $5.18.
People also own
Based on the portfolios of people who own SLS. This list is generated using Robinhood data, and it’s not a recommendation.